Hirata, K., Sakai, F., Hasebe, M., Takeshima, T., Numachi, Y., Yoshida, R., . . . Cheng, S. Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: Results from a 28-week open-label treatment period of a randomised trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationHirata, Koichi, et al. Long-term Efficacy and Safety of Erenumab in Japanese Patients with Episodic and Chronic Migraine: Results from a 28-week Open-label Treatment Period of a Randomised Trial. BMJ Publishing Group.
MLA (9th ed.) CitationHirata, Koichi, et al. Long-term Efficacy and Safety of Erenumab in Japanese Patients with Episodic and Chronic Migraine: Results from a 28-week Open-label Treatment Period of a Randomised Trial. BMJ Publishing Group.